WallStSmart
GNPX

Genprex Inc

NASDAQ: GNPX · HEALTHCARE · BIOTECHNOLOGY

$0.98
+12.07% today

Updated 2026-04-30

Market cap
$8.41M
P/E ratio
P/S ratio
EPS (TTM)
$-17.40
Dividend yield
52W range
$1 – $55
Volume
1.1M

Genprex Inc (GNPX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$0.00$0.00$0.00$0.00$13070.00$22777.00$22534.00$25575.00$15004.00$6693.00
Gross profit$0.00$0.00$0.00$0.00$-13070.00$-22777.00$-22534.00$-25575.00$-15004.00$-6693.00
Gross margin
R&D$201962.00$354883.00$289934.00$971427.00$1.97M$7.30M$8.97M$11.51M$17.62M$10.54M$9.43M
SG&A$865696.00$3.78M$3.02M$11.39M$11.39M$10.64M$10.97M$12.30M$13.44M$10.63B$6.09M
Operating income$-1.07M$-4.13M$-3.31M$-12.36M$-10.68M$-17.96M$-20.67M$-23.83M$-31.08M$-21.17M$-15.52M
Operating margin
EBITDA$-1.07M$-4.13M$-3.31M$-12.33M$-10.64M$-17.92M$-20.64M$-23.72M$-31.06M$-21.10M$-15.49M
EBITDA margin
EBIT$-1.07M$-4.13M$-3.31M$-12.33M$-10.65M$-17.94M$-20.66M$-23.74M$-31.08M$-21.11M
Interest expense$0.00$0.00$1890.00$37982.00$37982.00$0.00$5133.00$18.11M$0.00$739935.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-1.07M$-4.13M$-3.31M$-12.37M$-10.65M$-17.94M$-20.66M$-23.74M$-30.86M$-21.11M$-16.23M
Net income growth (YoY)-286.3%+19.8%-273.3%+13.9%-68.4%-15.2%-14.9%-30.0%+31.6%+23.1%
Profit margin